Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis

被引：0
|
作者：
Saag, K. G. [1 ]
Shane, E. [2 ]
Boonen, S. [3 ]
Donley, D. W. [4 ]
Marin, F. [4 ]
Warner, M. R. [4 ]
Taylor, K. A. [4 ]
Dalsky, G. R. [4 ]
Marcus, R. [4 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[3] Katholieke Univ Leuven, Div Geriatr Med, Louvain, Belgium
[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [31] Correlations between bone turnover markers and BMD in patients treated with teriparatide or alendronate for glucocorticoid-induced osteoporosis
    Burshell, A. L.
    Moericke, R.
    Correa-Rotter, R.
    Chen, P.
    Warner, M. R.
    Krege, J. H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S128 - S128
  • [32] COMPARISON OF THE EFFICACY OF DENOSUMAB AND ALENDRONATE IN GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Iseri, Ken
    Iyoda, Masayuki
    Watanabe, Makoto
    Matsumoto, Kei
    Sanada, Daisuke
    Inoue, Takashi
    Tachibana, Shohei
    Shibata, Takanori
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 235 - 235
  • [33] Treatment of glucocorticoid-induced osteoporosis
    Mazziotti, Gherardo
    Giustina, Andrea
    Canalis, Ernesto
    Bilezikian, John P.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2009, 1 (01) : 27 - 34
  • [34] The treatment of glucocorticoid-induced osteoporosis
    Cohen, D
    Adachi, JD
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 88 (4-5): : 337 - 349
  • [35] Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases
    Inoue, Yuzaburo
    Shimojo, Naoki
    Suzuki, Shuichi
    Arima, Takayasu
    Tomiita, Minako
    Minagawa, Masanori
    Kohno, Yoichi
    CLINICAL RHEUMATOLOGY, 2008, 27 (07) : 909 - 912
  • [36] Prevention of glucocorticoid-induced osteoporosis: A randomized clinical trial with alendronate versus alfacalcidol. The Stop-Study
    de Nijs, R
    Jacobs, J
    Buskens, E
    Huisman, A
    Algra, A
    Laan, R
    de Laet, C
    Lems, W
    Bijlsma, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 94 - 94
  • [37] Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases
    Yuzaburo Inoue
    Naoki Shimojo
    Shuichi Suzuki
    Takayasu Arima
    Minako Tomiita
    Masanori Minagawa
    Yoichi Kohno
    Clinical Rheumatology, 2008, 27 : 909 - 912
  • [38] An effect comparison of alendronate and teriparatide in patients with glucocorticoid-induced osteoporosis: A protocol for systematic review and meta-analysis
    Liang, Na
    Zhang, Shuang
    Wang, Shuang
    Ma, Juan
    MEDICINE, 2022, 101 (48) : E32090
  • [39] Consistency of effect of alendronate in glucocorticoid-induced and postmenopausal osteoporosis.
    Ernkey, R
    Saag, K
    Brown, J
    Correa-Rotter, R
    Malice, MP
    Carofano, W
    Dalfotis, A
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S44 - S44
  • [40] Prevention of glucocorticoid-induced osteoporosis with alendronate compared with alphacalcidol.
    de Nijs, RNJ
    Jacobs, WG
    Algra, A
    Buskens, E
    Huisman, M
    de Laet, CED
    Laan, RFJ
    Lems, WF
    Biljlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S497 - S497
12345